Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05479552 · ClinicalTrials.gov registry record
A Diagnostic Test for Dementia With Lewy Bodies
A clinical trial of MCI-AD, Early Stage Alzheimer's Disease and MCI-DLB, Early Stage Dementia With Lewy Bodies, sponsored by CND Life Sciences.
- Active
- Registry status
- 80
- Enrollment target
- 12
- Study locations
NCT05479552 is a study of MCI-AD, Early Stage Alzheimer's Disease and MCI-DLB, Early Stage Dementia With Lewy Bodies that is active but no longer recruiting, run by CND Life Sciences. The registered enrollment target is 80 participants. The trial reports 12 study locations across 9 states.
The verdict
NCT05479552, a study of MCI-AD, Early Stage Alzheimer's Disease and MCI-DLB, Early Stage Dementia With Lewy Bodies, is active but no longer recruiting, sponsored by CND Life Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 12
- Study locations
Study Summary
The Syn-D Study will be evaluating α-synuclein in patients with suspected MCI-AD and MCI-DLB. Using a simple diagnostic test will improve clinical accuracy in diagnosing, earlier diagnosis, and distinguish between neurodegenerative diseases.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Syn-One Test
Study Locations (12)
Massachusetts
- Mass General Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
- Headlands Research - Plymouth
Florida
- University of Miami - Boca Raton
- Neurology One - Winter Park
Arizona
- CND Life Sciences - Scottsdale
California
- University of California San Diego - La Jolla
Colorado
- CenExel RMCR - Englewood
Louisiana
- Ochsner Research - New Orleans
Michigan
- University of Michigan - Ann Arbor
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2025-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05479552
The ClinicalTrials.gov registry entry for NCT05479552 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CND Life Sciences, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with MCI-AD, Early Stage Alzheimer's Disease appearing as the primary indexed condition, and to 1 intervention - of which Syn-One Test is the first listed.
NCT05479552 reports 12 study locations spanning 9 distinct geographic areas - top geographies include Massachusetts, Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT05479552 about?
NCT05479552 is a clinical study titled "A Diagnostic Test for Dementia With Lewy Bodies". The Syn-D Study will be evaluating α-synuclein in patients with suspected MCI-AD and MCI-DLB. Using a simple diagnostic test will improve clinical accuracy in diagnosing, earlier diagnosis, and distinguish between neurodegenerative diseases.
What is the current status of trial NCT05479552?
This trial is currently active not recruiting. The enrollment target is 80 participants. The study started on 2022-08-15. Estimated completion is 2025-10-31.
What conditions does trial NCT05479552 study?
This clinical trial studies the following conditions: MCI-AD, Early Stage Alzheimer's Disease, MCI-DLB, Early Stage Dementia With Lewy Bodies.
What interventions are being tested in trial NCT05479552?
The interventions under investigation include: Syn-One Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05479552?
This trial is sponsored by CND Life Sciences, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05479552 being conducted?
This trial has 12 study locations across Arizona, California, Colorado, Florida, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
MCI-AD, Early Stage Alzheimer's Disease
All registered trials for this condition
MCI-DLB, Early Stage Dementia With Lewy Bodies
All registered trials for this condition
Arizona
All trials with a study site in Arizona
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.